Log In
Print this Print this

OncoFluVec (VTH 202)

  Manage Alerts
Collapse Summary General Information
Company Vacthera BioTech GmbH
DescriptionOncolytic influenza prototype that replicates in tumor cells
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today